Trial Profile
Evaluation of dose responsiveness for T-705a in the treatment of seasonal infection with influenza
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Toyama Chemical
- 30 May 2016 New trial record